It is ironic that all of this is supposed to be about saving lives from a virus… yet much of what the media, social media companies, and government leaders have been doing is suppressing life saving treatments that have been PROVEN safe and effective for many years. But then they would not have been able to get the Emergency Use Authorizations from the FDA for these experimental gene therapy shots on human beings.
And they would not be putting forth their Great Reset agenda.
They have suppressed life saving treatments and information about drugs like ivermectin, hydroxxx, supplements like NAC, and downplayed the importance of the Vitamins D3, K and C, plus quercetin and zinc (MATH protocol).
For prevention suggests Dr. Mercola:
'We are forced to publicly expose what we believe can only be described as a “disinformation” campaign [against #ivermectin] astonishingly waged with full cooperation of those authorities whose mission is to maintain the integrity of scientific research and protect public health.'
https://covid19criticalcare.com/.../flccc-alliance.../
All they’ve been promoting are experimental gene therapy shots 24/7 that have been reported to the VAERS CDC system with 5,800+ deaths in the USA and as of June 4th, there have been 329,021 of reactions to the v@cc!ne reported. And many more in Europe.
One pharmacist quit her job at CVS refused to give people shots.
The U.S. Food and Drug Administration is suddenly cracking down on N-acetylcysteine (NAC), claiming it is excluded from the definition of a dietary supplement. As a result, Amazon has removed all listings featuring NAC-containing supplements
The trade group for the supplement industry, the Council for Responsible Nutrition, is challenging the FDA’s position, calling it “legally invalid,” and is urging its members to continue selling NAC supplements
NAC supplements have been sold for 57 years, and the FDA has never taken action against it — until now, when 16 clinical trials are investigating its usefulness against COVID-19
NAC is a precursor to reduced glutathione, which appears to play a crucial role in COVID-19. There’s evidence glutathione deficiency may worsen COVID-19 severity
NAC inhibits expression of proinflammatory cytokines that can trigger a cytokine storm, improves T cell response, benefits a variety of lung problems, and inhibits the hypercoagulation that can result in stroke and/or blood clots that impair the ability to exchange oxygen in the lungs
N-acetylcysteine (NAC), a precursor to reduced glutathione, appears to play an important role in COVID-19. According to an April 2020 literature analysis, glutathione deficiency may be associated with COVID-19 severity, leading the author to conclude that NAC may be useful both for its prevention and treatment.
NAC has a long history of use as a poison control remedy for acetaminophen poisoning in the emergency room. It neutralizes the toxic effects of the drug by recharging glutathione, thereby preventing liver damage. But the idea that NAC can also be helpful against viral infections is not new. Previous studies have found it reduces viral replication of certain viruses, including the influenza virus.
N-acetylcysteine (NAC) has a long history of use as a first-aid remedy for acetaminophen poisoning. Emergency room physicians will administer it in cases when you’ve taken an overdose of Tylenol or other acetaminophen products. The way it neutralizes the toxic effects of the drug is by recharging glutathione, thereby preventing liver damage.
In one such study, the number needed to treat (NNT) was 0.5, which means for every two people treated with NAC, one will be protected against symptomatic influenza. That’s significantly better than influenza vaccines, which have an NNV (number needed to vaccinate) of 71,5 meaning 71 people must be vaccinated to prevent a single case of confirmed influenza. It’s even better than vitamin D, which has an NNT of 33.
Early At-Home Treatment Is Crucial
MedCram producer and cofounder Kyle Allred interviews Dr. Roger Seheult, a pulmonologist who has been treating COVID-19 patients since the beginning of the pandemic in 2020, about strategies that can significantly reduce your need for hospitalization should you contract this infection.
Among those strategies is the use of NAC, which used to be readily available over the counter and online. Disturbingly, as more information is coming out about the usefulness of NAC, the U.S. Food and Drug Administration is now clamping down on sales.
Since the beginning of this pandemic, global and national health authorities have done everything in their power, it seems, to discourage and prevent people from accessing any treatment that competes with the COVID jab. This appears to be yet another shameful attempt to prevent patients from helping themselves and boost the risk of infections progressing into more serious cases.
Should you come down with symptoms of COVID-19, early treatment is crucial. Not only can it significantly reduce the length of time that you’re sick, early treatment will also minimize your risk of long-hauler syndrome. A summary of the treatment strategies Seheult reviews in more detail in the video is as follows:
Monitor your oxygen saturation status using a pulse oximeter. If your oxygen saturation drops below 94% at rest, you should seek medical treatment. Below 90%, you are hypoxic and need supplemental oxygen
Use vitamins and other immune-boosting supplements, including vitamins C and D, quercetin, zinc and NAC, and/or medication
In December 2020, the trade group for the supplement industry, the Council for Responsible Nutrition (CRN), challenged the FDA’s position, calling it “legally invalid.”11 CRN argued that FDA records fail to prove that the FDCA section in question actually applies to NAC.
NAC has the ability to reduce mucus secretions and phlegm, as well as to reduce coughing, wheezing and trouble breathing. This makes it helpful in treating conditions including chronic bronchitis (defined as the presence of chronic productive coughs for more than three months in two consecutive years), as well as colds and the flu.
In addition, there’s evidence that it can be an adjunct treatment for chronic obstructive pulmonary disease (the fourth-leading cause of death in the United States) and emphysema.
NAC improves insulin sensitivity and can help those who are susceptible to developing metabolic disorders.
Between 600–1,800 milligrams of NAC daily seems to be effective against many conditions; 600-milligram capsules taken two to three times a day is the recommended dosage to start with.
There’s evidence that 2,000 milligrams is safe for most adults.
Higher doses may be needed to treat certain chronic and degenerative diseases, including COPD, impaired glucose control and cancer. For example, doses of about 2,800 milligrams per day for up to three months seem to be effective for adults with COPD, according to some studies.
In response to a Freedom of Information Act (FOIA) request to the FDA for information proving NAC was investigated as a drug in 1963, all they received was a handwritten letter containing “what appears to be a handwritten approval date of 1963” for an inhaled drug.
An inhaled substance cannot be treated the same as an orally ingested product, hence the NAC drug approved in 1963, if valid, still would not apply to oral supplements. The FDA did approve an NAC drug for oral-only use in 2016, but by then dietary supplement companies had already been marketing NAC supplements for several decades, and therefore cannot be canceled by a new drug approval.
Amazon has apparently decided to side with the FDA, despite the ongoing legal controversy and, as of this writing, has already removed all NAC product listings. Since Amazon owns Whole Foods Market, NAC products may be removed from brick and mortar stores as well. But that doesn’t mean you can’t find NAC elsewhere.
At present, ClinicalTrials.gov lists 16 clinical studies underway or completed involving NAC against COVID-19.14 That’s five more than there were in November 2020.
This includes a still-ongoing Phase 2 trial looking at NAC in patients with severe COVID-19..
Researchers have confirmed that in severe COVID-19 cases, cytokines such as interleukin-6 (IL6), interleukin-10 (IL10) and TNF-ɑ are all elevated. Once they reach excessive levels, a cytokine storm develops, causing significant tissue damage. NAC may be able to inhibit this damaging cascade.
Previous research has shown NAC inhibits the expression of proinflammatory cytokines in cells infected with highly pathogenic H5N1 influenza virus. Proinflammatory cytokines also play a crucial role in COVID-19 severity.
Researchers have confirmed that in severe COVID-19 cases, cytokines such as interleukin-6 (IL6), interleukin-10 (IL10) and TNF-ɑ are all elevated.18 Once they reach excessive levels, a so-called cytokine storm develops, causing significant tissue damage. NAC may be able to inhibit this damaging cascade.
A recent paper published on the preprint server ChemRxiv.org, June 1, 2021, hypothesizes NAC may be used to perturb the spike protein by reducing its solvent accessible disulfide bond, “thereby disintegrating its structural architecture.” By so doing, the virus loses its capacity to infect your cells.
Analyses have shown NAC causes a threefold weakening of the spike protein’s binding affinity with the ACE2 receptor. Other experiments have shown NAC inhibited SARS-CoV-2 replication in VEroE6 cells by 54.3%. According to the authors, “Our observed results open avenues for exploring in vivo pharmaco-preventive and therapeutic potential of NAC for COVID-19.”
NAC Shown to Improve Variety of Lung-Related Problems
Studies have also demonstrated that NAC helps improve a variety of lung-related problems, including pneumonia and ARDS, both of which are common characteristics of COVID-19.
NAC Also Protects Against Blood Clots
NAC may also protect against hypercoagulation that can result in stroke and/or blood clots that impair the ability to exchange oxygen in the lungs. Many COVID-19 patients experience serious blood clots, and NAC counteracts hypercoagulation, as it has both anticoagulant and platelet-inhibiting properties.
A 2017 paper also found NAC has potent thrombolytic effects, meaning it breaks down blood clots once they’ve formed. This is largely thanks to the sulfur in NAC (from cysteine). The sulfur reduces the intrachain disulfide bonds by von Willebrand factors that have polymerized by dissociating the sulfur bonds holding them together, thus contributing to the clot.
Once von Willebrand factor sulfur bonds are broken, the clots start to dissolve and the blood vessels open up again allowing for exchange of oxygen and carbon dioxide.
Two additional papers show the same thing. Importantly, NAC’s mechanism of action does not appear to increase bleeding disorders like heparin does, so it would likely be a safer alternative to the heparin used in the MATH+ protocol.